Volume surge · ILMN · Healthcare

Illumina Inc (ILMN) keeps 44.6% 12-week climb in focus

The diagnostics-and-research stock is drawing heavier activity as trend pressure improves, though Relative Strength remains below leadership territory.

Illumina Inc
Latest205.10 USD
1W move5.7%
Volume1.4x
TrendActive
Weekly market chart context for Illumina Inc with diagnostics and research equipment.

Market update

What happened

Illumina Inc (ILMN) closed at $205.10 for the week ended July 31, adding 5.7% over one week and 8.7% over four weeks. The chart shows a weekly price path over 52 weeks, not live intraday trading.

Confirming evidence is stronger on activity than on relative performance. Weekly volume reached 12,416,062 shares versus a 13-week average of 9,132,740, while Market Dynamics at 1.43 indicates positive pressure; Relative Strength at 43.4 keeps the setup mixed.

Continue your research

Explore ILMN across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

ILMN coverage

Evidence context